Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating cash flow changed -70.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Shares outstanding changed +231.1% from the comparable as-filed period. The change ranks at the 100th percentile of 5 prior comparable changes. This reverses 5 consecutive comparable moves in the opposite direction.
Current assets changed +478.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Working capital changed +899.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating income changed -366.7% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Net income changed -295.8% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Current liabilities changed +332.3% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Cash & equivalents changed +928.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a low base.
Total assets changed +10488.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a low base.
Operating margin changed +276473 basis points from the comparable as-filed period.
SBC / revenue changed +427 basis points from the comparable as-filed period.
Working capital / assets changed -2014 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Revenue changed +3590.3% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a low base.
Current ratio changed +33.8% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Operating cash-flow margin changed +286707 basis points from the comparable as-filed period.
R&D / revenue changed -132426 basis points from the comparable as-filed period.
Inventory changed -13.7% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Stock-based compensation changed +3655.2% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a low base.
Research & development changed -2.5% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.